Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-01-30
1996-09-24
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 28, 514 30, 514291, 536 71, 536 72, 536 74, C07H 1708, A61K 3170
Patent
active
055590985
ABSTRACT:
A stable topical formulation with good active ingredient release characteristics, comprising at least one macrolide antibiotic which is lipophilized with at least one former of oppositely charged ions which is selected from the group consisting of alkyl sulfates, alkylsulfonates, and alkyl salicylates, RX, where R represents a linear and/or branched alkyl group with 6-32 C atoms, and X represents a sulfate, sulfonate, or salicylate group.
REFERENCES:
patent: 3891755 (1975-06-01), Mehta
patent: 3922379 (1975-11-01), Farhadieh
patent: 3934013 (1976-01-01), Poulsen
patent: 4091090 (1978-05-01), Sipos
patent: 4474748 (1984-10-01), Sipos
patent: 4588744 (1986-05-01), McHugh
H. Bojarska-Dahlig, et al., Curr. Chemother. Immunother. Proc. Int. Congr. Chemother., 12th, Meeting Date 1981.
Arzneim.-Forsch./Drug Res., 37(II), No. 12, 1987, P. Langguth, et al., "Lipophilisation of Hydrophilic Compounds", pp. 1362-1366.
Bojarska-Dahlig, Halina et al, "Davercin: Chemistry and Biological Properties of the Cyclic 11,12-Carbonates in the Erythromycin Group," Current Chemotherapy and Immunotherapy, Jul. 1981, vol. 11, pp. 898-900.
Matschiner Sybille
Neubert Reinhard
Wellner Katrin
Wohlrab Wolfgang A.
Lilling Herbert J.
Roehm Pharma GmbH
LandOfFree
Stable topical formulations with good active ingredient release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable topical formulations with good active ingredient release , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable topical formulations with good active ingredient release will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928487